ABO and cystic fibrosis: This targeted study has generated important “negative” data regarding modifier genes in CF, which is not possible through SNP-based platforms (e.g. Ilumina 550K chip) because these platforms do not test for all of the pertinent SNPs necessary to establish ABO, Secretor and Lewis status.